Generics offer an equally safe and effective option as their branded counterparts as well as substantial savings. Discover #Biocon’s comprehensive range of high-quality #generics across various therapeutic areas. Visit this page to know more:
About us
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars. The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products. We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders. Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five’ people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years. We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets. We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin. Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector. Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster’ drugs with the potential to benefit a billion patients.
- Website
-
http://www.biocon.com
External link for Biocon
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Bangalore, Karnataka
- Type
- Public Company
Locations
-
Primary
Hosur Road, Electronics City
Bangalore, Karnataka 560100, IN
Employees at Biocon
Updates
-
#Bioconites recently participated in an awareness session with Dr Ravi Kiran S K – Hepatology & Liver transplantation, on ‘Hepatitis’. The session delving into a variety of topics like Hepatitis and its types, causes, symptoms, treatment and many more. #HepatitisAwareness #LiverHealth
-
#WelcomeToBiocon: Always excited to welcome new #Bioconites to the team! Congratulations, and we look forward to you contributing to our purpose of providing everyone, everywhere, affordable access to medicines. #Biocon
-
#WelcomeToBiocon: Always excited to welcome new #Bioconites to the team! Congratulations, and we look forward to you contributing to our purpose of providing everyone, everywhere, affordable access to medicines. #Biocon
-
Today, on Doctors' Day, we celebrate the incredible individuals whose hands heal and whose hearts care deeply for their patients. These dedicated professionals work tirelessly, often behind the scenes, to ensure our well-being and health. Their expertise and compassion make a profound difference in our lives every single day. Let's take a moment to express our gratitude and admiration for their unwavering commitment, their countless sacrifices, and their exceptional ability to provide comfort and care in times of need. To all the doctors out there, thank you for being our heroes, our healers, and our guiding lights. Happy Doctors' Day! #DoctorsDay #HealingHands #CaringHearts #ThankYouDoctors #HealthcareHeroes #MedicalHeroes
-
Happy World #SocialMediaDay! Social media is a powerful tool for connection, communication, and creativity. However, it's essential to stay in control and make conscious choices about how we engage online. Let's use social media wisely, harnessing its power for good and staying in charge of our digital lives. Together, we can create a positive and mindful online community!
-
At Biocon Group, our commitment to a sustainable future drives us to continually reduce our carbon footprint. By leveraging innovative solutions and optimizing our logistics, we are taking significant steps to protect our planet. Let’s #BeNaturePositive together! #EnvironmentMonth #Sustainability #RenewableEnergy
-
At #Biocon Group, we have taken several initiatives towards creating a sustainable and eco-friendly future. From nurturing biodiversity on our campuses to transforming waste sites into green spaces, we are committed to making a positive impact on our planet. #BeNaturePositive #EnvironmentMonth #Sustainability #EcoFriendly
-
At Biocon Group, we are dedicated to #BeNaturePositive with initiatives focused on water conservation. We use the latest technologies, such as zero liquid discharge systems and rainwater harvesting, to ensure minimum water wastage. #EnvironmentMonth #WaterConservation